Literature DB >> 17098573

Limited search strategies were effective in finding relevant nonrandomized studies.

Andrea D Furlan1, Emma Irvin, Claire Bombardier.   

Abstract

BACKGROUND AND
OBJECTIVE: Searching for nonrandomized studies in electronic databases is complicated because there is a variety of study designs and lack of standardization in the terminology. The purpose of this study was to develop and evaluate a method to limit search strategies according to study design of comparative nonrandomized studies (cNRSs).
METHODS: Four updated Cochrane systematic reviews that included nonrandomized studies (cohort, case-control, and cross-sectional studies) of the effects of health care interventions were selected. Search strategies limited to study design were devised for each one of these topic areas in two electronic databases (MEDLINE and EMBASE). A progressive method (PM) and a fixed method for selecting the most appropriate search terms associated with study design of nonrandomized studies are suggested.
RESULTS: The results showed that the sensitivity of search strategies (in two databases combined) limited to study design were between 90% and 100% for the PM using both controlled vocabulary (CV) and textwords (TWs) and between 95% and 100% for a fixed set of controlled vocabulary and TWs.
CONCLUSIONS: It is possible and acceptable to use search strategies limited to study design of cNRSs of health care interventions.

Mesh:

Year:  2006        PMID: 17098573     DOI: 10.1016/j.jclinepi.2006.03.004

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  14 in total

1.  Performance of a mixed filter to identify relevant studies for mixed studies reviews.

Authors:  Reem El Sherif; Pierre Pluye; Genevieve Gore; Vera Granikov; Quan Nha Hong
Journal:  J Med Libr Assoc       Date:  2016-01

Review 2.  Prostate cancer in systemic lupus erythematosus.

Authors:  S Bernatsky; R Ramsey-Goldman; C Gordon; A E Clarke
Journal:  Int J Cancer       Date:  2011-03-29       Impact factor: 7.396

Review 3.  Nonsteroidal Anti-inflammatory Drugs and Risk of Incident Heart Failure: A Systematic Review and Meta-analysis of Observational Studies.

Authors:  Patompong Ungprasert; Narat Srivali; Charat Thongprayoon
Journal:  Clin Cardiol       Date:  2015-12-31       Impact factor: 2.882

Review 4.  Changes in the macroscopic morphology of hip muscles in low back pain.

Authors:  Mohammadreza Pourahmadi; Mohammad Asadi; Jan Dommerholt; Ali Yeganeh
Journal:  J Anat       Date:  2019-09-01       Impact factor: 2.610

Review 5.  Post-exposure passive immunisation for preventing rubella and congenital rubella syndrome.

Authors:  Megan K Young; Allan W Cripps; Graeme R Nimmo; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2015-09-09

6.  Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis.

Authors:  S Bernatsky; R Ramsey-Goldman; W D Foulkes; C Gordon; A E Clarke
Journal:  Br J Cancer       Date:  2011-04-12       Impact factor: 7.640

7.  Search strategies to identify observational studies in MEDLINE and Embase.

Authors:  Li Li; Helen E Smith; Rifat Atun; Lorainne Tudor Car
Journal:  Cochrane Database Syst Rev       Date:  2019-03-12

Review 8.  Leisure in children and adolescents with juvenile idiopathic arthritis: a systematic review.

Authors:  Sabrina Cavallo; Karine Toupin April; Viviane Grandpierre; Annette Majnemer; Debbie Ehrmann Feldman
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

Review 9.  Total knee arthroplasty after high tibial osteotomy. A systematic review.

Authors:  Tom M van Raaij; Max Reijman; Andrea D Furlan; Jan A N Verhaar
Journal:  BMC Musculoskelet Disord       Date:  2009-07-20       Impact factor: 2.362

10.  Evaluating the impact and use of Transparent Reporting of Evaluations with Non-randomised Designs (TREND) reporting guidelines.

Authors:  Thomas Fuller; Mark Pearson; Jaime L Peters; Rob Anderson
Journal:  BMJ Open       Date:  2012-12-19       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.